Agent | Inhibitor category | Associated gene | Gene region | Cytoband | Number of probes in gene region | ρ for average region methylation vs log(IC50) | pFDR for average region methylation vs log(IC50) | Highest |r| for expression vs log(IC50) | Lowest p for expression vs log(IC50) | Highest |ρ| for expression vs region methylation | Lowest p for expression vs average region methylation | Transcript with lowest p for expression vs log(IC50) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT-348 | Aurora kinase | CEP350 | UTR3 | 1q25.2 | 1 | 0.6096 | 0.0953 | 0.0270 | 0.8281 | − 0.1887 | 0.1292 | NM_014810 (CEP350) |
ABT-737 | Bcl-2 | TCERG1L | UTR3 | 10q26.3 | 6 | − 0.6251 | 0.0787 | − 0.5740 | 3.81 × 10−7 | 0.6026 | 8.64 × 10−8 | NM_174937 (TCERG1L) |
AZD-1152 | Aurora kinase | MLPH | UTR3 | 2q37.3 | 1 | 0.6148 | 0.0905 | 0.3014 | 0.0132 | 0.5396 | 2.94 × 10-6 | NM_024101 (MLPH) |
BAL-101553 | Tubulin fragmenter | STARD3 | UTR3 | 17q12 | 5 | 0.6154 | 0.0905 | 0.0754 | 0.5440 | − 0.0173 | 0.8900 | NM_006804 (STARD3) |
BI-2536 | PLK-1 | MLPH | UTR3 | 2q37.3 | 1 | 0.6172 | 0.0905 | 0.2486 | 0.0425 | 0.5396 | 2.94 × 10-6 | NM_024101 (MLPH) |
BIA | GSK-3 | TTC15 | TSS200 | 2p25.3 | 4 | 0.6138 | 0.0905 | − 0.1191 | 0.3372 | − 0.1668 | 0.1807 | NM_016030 (TTC15) |
BIM-46187 | Pan-G-protein | C8orf74 | UTR5 | 8p23.1 | 1 | − 0.6721 | 0.0145* | |||||
BIM-46187 | Pan-G-protein | C8orf74 | Exon 1 | 8p23.1 | 1 | − 0.6721 | 0.0145* | |||||
BIM-46187 | Pan-G-protein | C8orf74 | TSS200 | 8p23.1 | 3 | − 0.6459 | 0.0530 | |||||
Depsipeptide | HDAC | MTERFD3 | Gene body | 12q23.3 | 1 | − 0.6468 | 0.0530 | 0.1686 | 0.1725 | − 0.3133 | 0.0104 | NM_001033050 (MTERFD3) |
Flavopiridol | CDK | SEC11C | TSS1500 | 18q21.32 | 4 | 0.6180 | 0.0905 | 0.0731 | 0.5566 | 0.5476 | 1.95 × 10-6 | NM_033280 (SEC11C) |
GSK-461364 | PLK-1 | LOC100128568 | Gene body | 19p13.3 | 20 | 0.6267 | 0.0787 | |||||
Sapanisertib | mTOR | SPG20 | UTR5 | 13q13.3 | 28 | 0.6252 | 0.0787 | − 0.3122 | 0.0101 | − 0.5423 | 2.55 × 10−6 | NM_001142295 (SPG20) |
Ivacaftor | MIF | TSS200 | 22q11.23 | 6 | 0.6144 | 0.0905 | − 0.2685 | 0.0280 | − 0.4318 | 0.0003 | NM_002415 (MIF) | |
Ivacaftor | RPUSD2 | Exon 1 | 15q15.1 | 4 | 0.6127 | 0.0913 | − 0.0729 | 0.5575 | − 0.0908 | 0.4683 | NM_152260 (RPUSD2) | |
ONX-0912 | Proteasome | CYP11B2 | Gene body | 8q24.3 | 1 | − 0.6078 | 0.0992 | − 0.1414 | 0.2536 | 0.1705 | 0.1711 | NM_000498 (CYP11B2) |
R-547 | CDK | GIGYF2 | TSS1500 | 2q37.1 | 4 | 0.6354 | 0.0639 | − 0.1255 | 0.3114 | − 0.1525 | 0.2215 | NM_001103147 (GIGYF2) |
R-547 | CDK | KCNH6 | UTR5 | 17q23.3 | 4 | 0.6409 | 0.0607 | 0.0677 | 0.5861 | 0.1664 | 0.1818 | NM_030779 (KCNH6) |
R-547 | CDK | TREX1 | Exon 1 | 3p21.31 | 9 | − 0.6119 | 0.0913 | |||||
R-547 | CDK | TREX1 | UTR5 | 3p21.31 | 6 | − 0.6109 | 0.0913 | |||||
SC-1 | Ras-GAP | WT1 | UTR3 | 11p13 | 1 | − 0.6372 | 0.0639 | − 0.3245 | 0.0074 | 0.4004 | 0.0009 | NM_024424 (WT1) |
SCH-1473759 | Aurora kinase | ITPA | UTR3 | 20p13 | 1 | − 0.6110 | 0.0913 | 0.0138 | 0.9115 | − 0.0562 | 0.6537 | NM_033453 (ITPA) |
SNS-314 | Aurora kinase | CEP350 | UTR3 | 1q25.2 | 1 | 0.6280 | 0.0787 | − 0.0704 | 0.5713 | − 0.1887 | 0.1292 | NM_014810 (CEP350) |
TAK-901 | Aurora kinase | TREX1 | Exon 1 | 3p21.31 | 9 | − 0.6231 | 0.0796 | |||||
TAK-901 | Aurora kinase | TREX1 | UTR5 | 3p21.31 | 6 | − 0.6088 | 0.0969 | |||||
TAK-960 analog | PLK-1 | GLYATL1 | TSS1500 | 11q12.1 | 2 | 0.6164 | 0.0905 | 0.1228 | 0.3223 | 0.4304 | 0.0003 | NM_080661 (GLYATL1) |
Vertex ATR inhibitor Cpd 45 | ATR | TREX1 | Exon 1 | 3p21.31 | 9 | − 0.6244 | 0.0787 | |||||
Vertex ATR inhibitor Cpd 45 | ATR | TREX1 | UTR5 | 3p21.31 | 6 | − 0.6182 | 0.0905 |